-
Top 19 most-performing biotech stocks of 2024
27 Jan 2025 20:12 GMT
… resilience in 2024. Indeed some biotech stocks recorded spectacular performance this … ) provided a much-needed non-steroid inhaled treatment option for patients … , responsible for hallucinogenic effects.
The biotech company’s stock performance skyrocketed …
-
How Molecule is accelerating medical research through tokenised IP and decentralised biotech funding
23 Jan 2025 10:49 GMT
… patients, scientists, investors, biotech DAOs, and novel crowdfunding … ;s like crowdfunding on steroids, where instead of getting … of projects and hiring biotech experts to drive the …
• Mice at Tracked Biotechnologies via MouseWatcher
The credibility …
-
Why This Top Biotech Stock Launched 19% Over Four Days
16 Jan 2025 18:04 GMT
… 's also not a steroid.
Though it's still … at a record high, the biotech stock also hit an intraday …
-
Pluri Congratulates Mesoblast on FDA Approval of First Mesenchymal Stromal Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease
19 Dec 2024 13:00 GMT
… MSC-based therapy for steroid-refractory acute graft-versus … https://pluri-biotech.com/solutions-pluri- … and is pioneering a biotech revolution that promotes global … Contacts Investors: investor.relations@pluri-biotech.com Israel Media: Shachar …
-
Mesoblast to be Added to Nasdaq Biotechnology Index
18 Dec 2024 12:30 GMT
… Benchmark as either Biotechnology or Pharmaceuticals. The Nasdaq Biotechnology Index is calculated … . Companies in the Nasdaq Biotechnology Index must meet eligibility requirements … in children and adults including steroid refractory acute graft versus host …
-
Top 1% Biotech Hits The Stratosphere On FDA Approval
19 Dec 2024 00:03 GMT
… . host disease. The top-notch biotech stock rocketed Thursday.
↑
X
NOW … year, half will develop GVHD. Steroids only work in about half … doesn't respond to steroids is a "devastating condition … younger than age 12 with steroid-refractory GVHD, he said. …
-
VivaVision to advance non-steroidal therapy in Phase III following Phase II win
04 Dec 2024 17:59 GMT
… headquartered VivaVision Biotech is looking to advance its non-steroidal therapy, VVN461 … long-term use of steroids can have side effects ranging … . VVN461 is a non-steroidal dual JAK1/TYK2 … for neurotrophic keratitis, and non-steroidal dual JAK1/TYK2 …
-
Lipella Pharmaceuticals Announces Publication in CUREUS on Non-Steroid Treatment of Oral Lichen Planus
03 Dec 2024 13:30 GMT
… Nasdaq: LIPO), a clinical-stage biotechnology company dedicated to addressing serious … paper focuses on non-steroid treatments for oral lichen … tacrolimus. TCIs are non-steroidal medications used to treat … that may offer a steroid-sparing approach. This peer …
-
Founder mode on steroids: The Israeli secret to startup survival and success
28 Nov 2024 07:12 GMT
… of Israeli founder mode on steroids.
Let's look at … with unmatched urgency.
Immunai: This biotech powerhouse is revolutionizing personalized medicine … exemplifies Israeli founder mode on steroids.
Wiz.ai: Just four years …
-
Adverum Biotechnologies shares positive 52-week LUNA and 4-year OPTIC results
21 Nov 2024 22:16 GMT
… multiple prophylactic regimens, including topical steroid eyedrops (difluprednate) with or without … 2025.
Reference:
1. Adverum Biotechnologies Announces Positive 52-Week LUNA … Pivotal Program Design Elements. Adverum Biotechnologies, Inc. November 18, 2024. …
About
© 1995-2025